BioNexus Gene Lab Corp - (BGLC) share price
BioNexus Gene Lab Corp - (NASDAQ:BGLC) last traded at $0.83, down 3.09% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.00B and a 52-week range of $0.83 to $5.41.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $0.83 |
| 1-day move | -3.09% |
| 52-week range | $0.83 - $5.41 |
| Market cap | $0.00B |
| From 52-week high | -84.70% |
| Volume vs average | 0.7x |
| Falling Shares risk score | 52/100 (HIGH) |
| Country | United States |
Frequently asked questions
Why is BioNexus Gene Lab Corp - falling today?
BioNexus Gene Lab Corp - (NASDAQ:BGLC) is down 3.09% at its latest quote and trades 84.7% below its 52-week high, at a new 52-week low. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the BioNexus Gene Lab Corp - share price today?
BioNexus Gene Lab Corp - (NASDAQ:BGLC) last traded at $0.83, a -3.09% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of BioNexus Gene Lab Corp -?
BioNexus Gene Lab Corp -'s 52-week low is $0.83 and its 52-week high is $5.41; the shares trade 84.7% below the high.
What is the market cap of BioNexus Gene Lab Corp -?
BioNexus Gene Lab Corp - has a market capitalisation of about $0.00B at the latest price.
What are the risks of investing in BioNexus Gene Lab Corp -?
Falling Shares Intelligence rates BioNexus Gene Lab Corp - 52/100 (HIGH) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com